For research use only.
KPV
KPV is a tiny piece of alpha-MSH, a natural hormone, just three amino acids long, and it has been studied in mice for gut inflammation.[1]
Research areas
The research so far is in cells and animals.[3]
Evidence level
Level 1 of 4: Lab and animal onlyFDA found no clinical studies or other human data on KPV by any route.[3]
Why so few human trials?Cautions
Studies and regulators point to several reasons for care.
- FDA has not found any human exposure data, so it lacks the information to know whether KPV would harm people[5]
- FDA found no animal toxicity or cancer studies to judge its safety[3]
- How KPV works is still unclear, since lab tests suggest it doesn’t act through alpha-MSH’s usual receptors[3]
- In a lab test on human skin, KPV did not pass well through the skin’s outer layer[3]
KPV is not FDA approved.[3]
KPV goes by several names.
- Lys-Pro-Val, or lysine-proline-valine[3]
- Alpha-MSH(11-13), meaning amino acids 11 to 13 of alpha-MSH[1]
- KPV acetate, its salt form[3]
Often paired with
GHK-Cu, BPC-157 and TB-500. Together the four are known as the KLOW blend.[6]
Good to know
Unlike alpha-MSH, KPV doesn’t affect skin pigment but keeps the hormone’s anti-inflammatory effect, which is why researchers proposed it for inflammation.[7]
Storage basics General
These general basics apply to most freeze-dried research peptides.
Sources and studies
These studies and official pages are the research behind this profile.
- 1Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel diseaseKannengiesser K, et al. (2008) · Inflammatory Bowel Diseases
- 2Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSHHiltz ME, Lipton JM (1989) · The FASEB Journal
- 3July 23-24, 2026, Meeting of the Pharmacy Compounding Advisory Committee: FDA Briefing Document for KPV-Related Bulk Drug Substances (KPV (Free Base) and KPV Acetate)U.S. Food and Drug Administration (2026)
- 4PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationDalmasso G, et al. (2008) · Gastroenterology
- 5Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksU.S. Food and Drug Administration (2026)
- 6KLOW: what is and is not known about the blendMolecular Recovery (2026)
- 7Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseasesBrzoska T, et al. (2008) · Endocrine Reviews